Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-05-24
2005-05-24
Raymond, Richard L. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S359000, C514S385000, C514S387000, C514S393000, C514S396000, C514S406000, C548S100000, C548S300100, C548S300700, C548S303100, C548S356100, C548S360100, C548S364100
Reexamination Certificate
active
06897208
ABSTRACT:
The invention is directed to physiologically active compounds of the general formula (Ix)and compositions containing such compounds, and their prodrugs, and pharmaceutically acceptable salts and solvates of such compounds and their prodrugs, as well as to novel compounds within the scope of formula (Ix), and to processes for their preparation. Such compounds and compositions have valuable pharmaceutical properties, in particular the ability to inhibit kinases.
REFERENCES:
patent: 3839575 (1974-10-01), Gauss et al.
patent: 5958950 (1999-09-01), Padia et al.
patent: 6358978 (2002-03-01), Ritzeler et al.
patent: 2130029 (1972-12-01), None
patent: 2263878 (1973-07-01), None
patent: 1006114 (2000-06-01), None
patent: 2001002369 (2001-01-01), None
patent: WO0153268 (2001-07-01), None
patent: 2001053268 (2001-07-01), None
patent: WO03004488 (2003-01-01), None
Chemical Abstract DN 107:39769, also cited as Bull. des Soc. Chim. Belgesd 96/1,63-7(1987).*
Chemical Abstract DN 135:137505, also cited as WO 2001053268 dated Jul. 2001.*
Chemical Abstract DN 130:22167, also cited as J. Coputer-Aided Molecular Design 12/4,361-72(1998).*
Essassi et al Chemical Abstract DN 107:39769, also cited as BUll. des Soc. Chim. Belges. 96/1,63-7(19876).*
Reicj et al, Chemical Abstract DN 135:137505, also cited as WO 2001053268 dated Jul. 2001.*
Fossa et al, Chemical Abstract DN 130:22167, also cited as J. Computer added Molecular Design, 12/4,361-72(1998).*
Cecil Textbook of Medicine, 2oth Edition, vol. 1,1004-1010(1996).*
Ucxkum et al, Current Cancer Drug Targets, 1,59-71(2001).*
Cecil Textbook of Medicine, 2oth Edition, vol. 2,1992-1996(1996).*
PubMed Abstract 11426063,also cited as J. Biosci.26/2,271-6(2001).*
PubMed Abstract 1418038, also cited as Arzneimittleforschung, 42/6,821-4(1992).*
PubMed Abstract 12384531, also cited as Cancer res.,62/20,5727-35(2002).*
Andreichikov, Yu. S. et al., Dihydro-1,2-diazaphenazines, Khim. Geterotsikl. Soedin., No. 12, 1974, pp. 1690-1694, Abstract only, XP-002204303.
Essassi, E.M. et al., Synthese et Hererocyclisation des (Pyrazolyl-3(5))-2 Benzimidazoles en Catalyse par Transfert de Phase, Bulletin des Societes Chimiques Belges, vol. 96, No. 1, 1987, pp. 63-67, XP-008005414.
Farag, Ahmad M. et al., Regioselective Synthesis of Novel 1-Methyl-2-(4-aryl-5-cyano-1,3-diphenyl-4,5-dihydropyrazol-5-yl)benzimidazoles and 2-(4-aryl-5-cyano-1,3-diphenyl-4,5-dihydropyrazol-5-yl)benzothiazoles via benzonitrilium N-phenylimide, J. Chem. Res., Synop., No. 7, 1994, pp. 286-287, Abstract only—XP-002204304.
Finar, I. L. et al., The Preparation and Some Reactions of 4-Formyl-1-phenyl-pyrazoles, Journal of the Chemical Society, 1961, pp. 2733-2738, XP-002204301.
Hubert, Andre J. et al., Thermolyse von v-Triazolyl-Derivalen, Chemische Berichte, vol. 103, No. 12, 1970, pp. 3811-3816, XP-002204297.
Joshi, Krishna C. et al., Investigation of the Reactions of 2-Hydrazino-Benzimidazoles with B-diketones: Synthesis of 2-(3,5-Disubstituted-1 H-pyrazole-1-yl)benzimidazoles, Journal of Heterocyclic Chemistry, vol. 25, No. 6, 1988, pp. 1641-1643, XP-002204298.
Saha, Nityanada et al., Synthesis, Characterization and Coordinating Properties of a New Benzimidazolylpyrazole: cobalt (II), nickel (II) and copper (II) complexes of 5-methyl-3-(2′-benzimidazolyl)pyrazole, J. Indian Chem. Soc., vol. 70, No. 11-12, 1993, pp. 1035-1042, Abstract only—XP-002204302.
Senga, Keitaro et al., Synthesis of Pyrazolo[1′,5′:1,2]-1,3,5-triazino[5,6-a]benzimidazoles, Journal of Heterocyclic Chemistry, vol. 12, No. 5, 1975, pp. 899-901, XP-002204300.
Singh, Shiv P. et al., Formation and Dehydration of a Series of 5-hydroxy-5-trifluoromethyl-4,5-dihydropyrazoles, Journal of Fluorine Chemistry, vol. 94, No. 2, 1999, pp. 199-203, XP-004163162.
Soos, T. et al., Novel Thermal Rearrangement of Fused Diaryl-v-Triazolium Salts to Neutral Indazole Derivatives. Fused Azolium Salts. 16, Journal of Organic Chemistry, vol. 62, No. 4, 1997, pp. 1136-1138, XP-002204296.
Takagi, Kaname et al., Synthesis of Pyrimidino[4,5-b][1,5]benzodiazepin-2-ones and Pyrimidino[1,6-a]benzimidazol-1-ones from 4-Ethoxycarbonylamino-1H-1,5-benzodiazpine-3-carbonitrile via 4-(2-Aminoanilino)pyrimidin-2(1H)-one-5-carbonitriles. Journal of Heterocyclic Chemistry, vol. 23, No. 5, 1986, pp. 1443-1449, XP-002204299.
Vereshchagina et al., Chemical Name: 2-(5-methyl-1H-[1,2,4]triazol-3-yl)-1H-benzoimidazole, Khim. Farm. Zh., vol. 7, No. 6, 1973, p. 18, Abstract only—XP-002204305.
Amendola Shelley
Babin Didier
Bouchard Herve
Cherry Michael
Cox Paul J.
Aventis Pharmaceuticals Inc.
Darkes Paul
Parker III Raymond S.
Patel Sudhaker B.
Raymond Richard L.
LandOfFree
Benzimidazoles does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benzimidazoles, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzimidazoles will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3461229